Stay updated on CA-4948 in CNS Lymphoma: Clinical Trial
Sign up to get notified when there's something new on the CA-4948 in CNS Lymphoma: Clinical Trial page.

Latest updates to the CA-4948 in CNS Lymphoma: Clinical Trial page
- Check3 days agoChange DetectedThe study record for the emavusertib trial in relapsed or refractory primary central nervous system lymphoma is now displayed, including its study design, eligibility criteria, outcomes, and participating locations.SummaryDifference86%

- Check10 days agoChange DetectedThe ClinicalTrials.gov page continues to display a 403 Forbidden error, with the footer revision updated from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check17 days agoNo Change Detected
- Check24 days agoChange DetectedA site-wide NIH notice about terminology changes appears above the page, and the site revision label updates from v3.7.1 to v3.7.2.SummaryDifference1%

- Check38 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the 403 error page.SummaryDifference0.2%

- Check52 days agoChange DetectedAccess to the study page now displays a 403 Forbidden error page, replacing the usual study record content. The visible page shows site chrome and a footer, indicating an access/server issue rather than updated study information.SummaryDifference20%

- Check59 days agoChange DetectedNew label 'Find contact information' appears and the revision tag updated to v3.7.0. The previous label 'Find Contact Information' and revision tag v3.6.6 were removed.SummaryDifference0.1%

Stay in the know with updates to CA-4948 in CNS Lymphoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CA-4948 in CNS Lymphoma: Clinical Trial page.